Detalhe da pesquisa
1.
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial.
Gynecol Oncol
; 182: 7-14, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246047
2.
Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern.
Int J Gynecol Pathol
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294049
3.
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045.
Int J Cancer
; 153(12): 2032-2044, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602928
4.
Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity Score Matching Study in Korea and Taiwan.
Ann Surg Oncol
; 30(11): 6855-6864, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386310
5.
Arteriovenous Malformation Associated with Intravenous Leiomyomatosis of the Uterus: Characteristic CT Findings and Treatment by Embolization and Surgery.
J Vasc Interv Radiol
; 34(1): 103-107, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36241150
6.
Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses.
Int J Mol Sci
; 24(18)2023 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37761976
7.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
N Engl J Med
; 381(20): 1929-1939, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722153
8.
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study.
Gynecol Oncol
; 165(1): 97-104, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35153073
9.
Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery.
Gynecol Oncol
; 165(3): 493-499, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367074
10.
Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification.
Int J Gynecol Cancer
; 32(12): 1524-1530, 2022 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368708
11.
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial.
Lancet Oncol
; 22(5): 632-642, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33862001
12.
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1721-1731, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34715071
13.
Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.
Cancer Sci
; 112(12): 5055-5067, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657357
14.
A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer.
Br J Cancer
; 124(2): 375-382, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32994466
15.
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 379(26): 2495-2505, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30345884
16.
Metabolic syndrome and persistent cervical human papillomavirus infection.
Gynecol Oncol
; 161(2): 559-564, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676760
17.
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial.
Lancet Oncol
; 21(12): 1653-1660, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33271094
18.
Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
Gynecol Oncol
; 157(2): 437-443, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107047
19.
CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer.
Gynecol Oncol
; 156(1): 211-221, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776040
20.
In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model.
J Minim Invasive Gynecol
; 27(2): 473-481, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959198